Name | Number of supported studies | Average coverage | |
---|---|---|---|
type I pneumocyte | 7 studies | 23% ± 4% | |
type II pneumocyte | 7 studies | 28% ± 6% | |
adipocyte | 6 studies | 22% ± 6% | |
hepatocyte | 3 studies | 20% ± 7% |
Insufficient scRNA-seq data for expression of ACADL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 3296.62 | 653 / 653 | 95% | 15.09 | 573 / 605 |
kidney | 100% | 1118.26 | 89 / 89 | 94% | 24.60 | 851 / 901 |
prostate | 97% | 2791.58 | 238 / 245 | 96% | 21.11 | 484 / 502 |
liver | 99% | 1382.08 | 224 / 226 | 61% | 5.27 | 248 / 406 |
pancreas | 100% | 2046.20 | 328 / 328 | 24% | 0.84 | 42 / 178 |
lung | 88% | 1162.45 | 508 / 578 | 28% | 1.37 | 319 / 1155 |
blood vessel | 99% | 2978.91 | 1323 / 1335 | 0% | 0 | 0 / 0 |
ovary | 97% | 1548.64 | 175 / 180 | 1% | 0.04 | 4 / 430 |
adipose | 95% | 804.48 | 1141 / 1204 | 0% | 0 | 0 / 0 |
muscle | 88% | 498.51 | 709 / 803 | 0% | 0 | 0 / 0 |
breast | 80% | 1051.17 | 368 / 459 | 8% | 0.49 | 86 / 1118 |
stomach | 77% | 487.17 | 275 / 359 | 0% | 0 | 0 / 286 |
skin | 46% | 186.78 | 838 / 1809 | 2% | 0.07 | 8 / 472 |
uterus | 24% | 116.19 | 41 / 170 | 17% | 0.89 | 78 / 459 |
adrenal gland | 12% | 44.77 | 31 / 258 | 22% | 3.75 | 50 / 230 |
heart | 27% | 117.08 | 235 / 861 | 0% | 0 | 0 / 0 |
brain | 8% | 32.22 | 214 / 2642 | 14% | 0.68 | 100 / 705 |
bladder | 5% | 18.33 | 1 / 21 | 11% | 0.60 | 54 / 504 |
esophagus | 11% | 65.58 | 160 / 1445 | 3% | 0.11 | 6 / 183 |
intestine | 3% | 15.21 | 27 / 966 | 2% | 0.07 | 13 / 527 |
tonsil | 0% | 0 | 0 / 0 | 2% | 2.03 | 1 / 45 |
spleen | 0% | 1.57 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0090181 | Biological process | regulation of cholesterol metabolic process |
GO_0042413 | Biological process | carnitine catabolic process |
GO_0019254 | Biological process | carnitine metabolic process, CoA-linked |
GO_0046322 | Biological process | negative regulation of fatty acid oxidation |
GO_0033539 | Biological process | fatty acid beta-oxidation using acyl-CoA dehydrogenase |
GO_0045717 | Biological process | negative regulation of fatty acid biosynthetic process |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0001659 | Biological process | temperature homeostasis |
GO_0042758 | Biological process | long-chain fatty acid catabolic process |
GO_0044242 | Biological process | cellular lipid catabolic process |
GO_0005739 | Cellular component | mitochondrion |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0050660 | Molecular function | flavin adenine dinucleotide binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0016401 | Molecular function | palmitoyl-CoA oxidase activity |
GO_0004466 | Molecular function | long-chain fatty acyl-CoA dehydrogenase activity |
GO_0000062 | Molecular function | fatty-acyl-CoA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ACADL |
Protein name | Long-chain specific acyl-CoA dehydrogenase, mitochondrial (LCAD) (EC 1.3.8.8) |
Synonyms | |
Description | FUNCTION: Long-chain specific acyl-CoA dehydrogenase is one of the acyl-CoA dehydrogenases that catalyze the first step of mitochondrial fatty acid beta-oxidation, an aerobic process breaking down fatty acids into acetyl-CoA and allowing the production of energy from fats (By similarity). The first step of fatty acid beta-oxidation consists in the removal of one hydrogen from C-2 and C-3 of the straight-chain fatty acyl-CoA thioester, resulting in the formation of trans-2-enoyl-CoA (By similarity). Among the different mitochondrial acyl-CoA dehydrogenases, long-chain specific acyl-CoA dehydrogenase can act on saturated and unsaturated acyl-CoAs with 6 to 24 carbons with a preference for 8 to 18 carbons long primary chains . . |
Accessions | P28330 ENST00000233710.4 |